TGFB1 and autoimmune disease: Therefore, an augmentation of TGF-β3 activity could be a potential therapeutic strategy for autoimmune diseases while avoiding glucose intolerance and scarring and fibrosis of other tissues, which might be induced by TGF-β1 modifying therapy.